BioCentury | Jan 16, 2014
Targets & Mechanisms
Putting a lid on cancer cell proteasomes
Blocking the catalytic activity of proteasomes is a tried-and-true strategy in multiple myeloma, but use of marketed inhibitors is limited by drug resistance and lack of efficacy in solid tumors. Now, a team from The...